Noticias de NVO_US
Noticias del mercado
Últimas noticias sobre NVO_US — 397 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Novo Nordisk aims for US approval for Ozempic for kids
Novo Nordisk to Seek Approval for Pill to Treat Diabetes in Young Patients
Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes
Novo Nordisk’s oral semaglutide demonstrates potential to be the first oral GLP-1 RA therapy for children and adolescents with type 2 diabetes
Biotech Investor Alex Karnal: GLP-1 Drugs Signal 'Trillion-Dollar Revolution' in Public Health
Delay in Medicare pilot for obesity drugs may not hurt near-term demand, analysts say
Experts see an ethical turning point at Novo following a new partnership: “It's horrifying”
Novo Nordisk A/S Stock (NVO) Moved Down by 3.60% on Apr 21: Facts Behind the Movement
Novo, Lilly drop as insurers are wary of joining Medicare GLP-1 coverage plan
Página 14 de 20
